Fenglin Li
Papers
1
Total Citations
10
H-Index
1
About
Dr. Fenglin Li is a biomedical researcher whose work centers on diabetic complications and natural product pharmacology, with a particular focus on diabetic nephropathy (DN)—a leading cause of kidney failure worldwide. Dr. Li’s most cited study, “Protective Effects of Xanthohumol against Diabetic Nephropathy in a Mouse Model” (2023, 10 citations), introduces a promising therapeutic avenue by demonstrating how the hop-derived compound xanthohumol mitigates renal damage in diabetic models. This work addresses the urgent need for more effective treatments, as DN contributes to millions of deaths annually and current therapies remain inadequate. By elucidating the molecular pathways through which xanthohumol exerts its protective effects—such as reducing oxidative stress and inflammation—Dr. Li’s research offers a foundation for developing novel, natural-based interventions. With growing recognition for bridging traditional pharmacology and modern disease mechanisms, Dr. Li’s contributions are poised to influence both preclinical drug development and clinical strategies for managing diabetic complications.
Research Focus
Key Achievements
Top Papers
- 1